World Class and Quadron Enter Into Arrangement Agreement
Tag: Ontario
Canadian Orebodies Completes Smoke Lake Drilling and Commences Sampling Historic Core
Canadian Orebodies Inc. (the “Company”) (TSXV:CORE) is pleased to announce that it has completed its previously announced drill program to explore for the extension and potential additional high-grade gold-bearing veins in the Smoke Lake Gold System (“SLGS”) on the Black Raven property (see press release dated February 22, 2019).
FSD Pharma Appoints Charles Pollack Jr. MD, FACEP as Chairman of the
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today the appointment of Charles V. Pollack, Jr., M.A., M.D., FACEP, FAAEM, FAHA, FACC, FESC, FCPP, as Chairman of its Scientific Advisory Board (“SAB”). In this capacity Dr. Pollack will serve as a strategic guide and resource to the Company as it develops disruptive, science-based, cannabinoid therapeutics.
FSD Pharma to Establish Presence in Canada’s Insurance Regimes
Signs agreement focusing on exploring insurance coverage for medical cannabis Canada wide –FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), announced today the signing of a consulting agreement with Joseph L. Romano, a well-respected lawyer with a strong track-record in personal injury law. Mr. Romano has been working with medical cannabis since 2006, assisting people coping with chronic pain to have access to medical cannabis, a viable alternative to opioid based medications.
2019-0322 – New Listing – World Class Extractions Inc. (PUMP)
The common shares of World Class Extractions Inc. have been approved for listing on the CSE.
FSD Pharma Announces New Leadership Appointment and Board Change
Dr. Sara May has been appointed as President of FV Pharma. Vladimir Klacar departs from FSD Pharma’s Board of Directors
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), a licensed producer under the Cannabis Act, today announced that Sara May, Ph.D., has been appointed President of FV Pharma (“FV”), a wholly owned subsidiary of FSD Pharma, effective immediately. Dr. May replaces Thomas Fairfull, former President of FV Pharma, as Mr. Fairfull transitions out of the company.
Canadian Orebodies: On Ice
Part of the challenge in exploration is matching data to theory at the tip of a drill. When Canadian Orebodies (V.CORE) purchased the Black Raven property in April 2017, the initial data that was inherited included a set of historical drill cores which had been drilled by a prior operator, Entourage Metals. This core suggested that there was a narrow, high-grade vein which was called the Super G.
Canadian Orebodies Commences Follow Up Drilling of High-Grade Gold Bearing Veins at Smoke Lake
Canadian Orebodies Inc. (the “Company”) (TSXV:CORE) is pleased to announce that it has commenced a drill program to explore the extension and potential additional high-grade gold-bearing veins in the Smoke Lake Gold System (“SLGS”) on the Black Raven property.
FSD Pharma Receives Standard Processing License
FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) announced today that its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”), a licensed cannabis producer under the Cannabis Act, has received its Standard Processing License (the “Processing License”). According to Health Canada’s new Cannabis Act regulations, the Processing License is required for any facility that is processing more than the equivalent of 600 kg of dried flowers per year.
FSD Pharma Provides Update on Operations, Strategy and Leadership
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD”), a licensed producer under the Cannabis Act, today provided a corporate update on operations, strategy and leadership changes.